Friday , 2 December 2022

About
Archives
Subscribe
E-Newsletter
Advertise
Contacts
Canadian Food Business

BioLab Business Magazine Together, we reach farther into the Canadian Science community

Home
Features
News & Newsmakers
Lab Profiles
Application Notes
Moments in Time
Events

Receive our E-newsletter

Receive Our E-newsletter

Name

First

Last

Last

Email

Title

Company Name

reCAPTCHA

Share

Facebook
Twitter
LinkedIn

Advertisement

New Edition

Advertisement

@Follow Us

Tweets by biolabmag

Advertisement

Advertisement

Latest News

Ventus Therapeutics Presents an Overview of its NLRP3 Inhibitors at Inflammasome Therapeutics Summit
Source: Lab Business Magazine Published on 2022-12-01
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
Source: Lab Business Magazine Published on 2022-12-01
AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases
Source: Lab Business Magazine Published on 2022-12-01
Aurinia Announces the Great Britain Marketing Authorization of LUPKYNIS® (voclosporin) for the Treatment of Lupus Nephritis
Source: Lab Business Magazine Published on 2022-11-30
MediPines Expands Distribution of AGM100 Pulmonary Gas Exchange Technology to Canada
Source: Lab Business Magazine Published on 2022-11-30
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
Source: Lab Business Magazine Published on 2022-11-30

© 2022 Dovetail Communications • Privacy Policy

We've promised to help prevent the spread of COVID-19

Honoured to have received a Gold award by the 2021 Tabbie Awards